BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27378813)

  • 1. ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.
    Murthy M; Kurz T; O'Shaughnessy KM
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27378813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
    McCormick JA; Yang CL; Zhang C; Davidge B; Blankenstein KI; Terker AS; Yarbrough B; Meermeier NP; Park HJ; McCully B; West M; Borschewski A; Himmerkus N; Bleich M; Bachmann S; Mutig K; Argaiz ER; Gamba G; Singer JD; Ellison DH
    J Clin Invest; 2014 Nov; 124(11):4723-36. PubMed ID: 25250572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.
    Schumacher FR; Siew K; Zhang J; Johnson C; Wood N; Cleary SE; Al Maskari RS; Ferryman JT; Hardege I; Yasmin ; Figg NL; Enchev R; Knebel A; O'Shaughnessy KM; Kurz T
    EMBO Mol Med; 2015 Oct; 7(10):1285-306. PubMed ID: 26286618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.
    Louis-Dit-Picard H; Kouranti I; Rafael C; Loisel-Ferreira I; Chavez-Canales M; Abdel-Khalek W; Argaiz ER; Baron S; Vacle S; Migeon T; Coleman R; Do Cruzeiro M; Hureaux M; Thurairajasingam N; Decramer S; Girerd X; O'Shaugnessy K; Mulatero P; Roussey G; Tack I; Unwin R; Vargas-Poussou R; Staub O; Grimm R; Welling PA; Gamba G; Clauser E; Hadchouel J; Jeunemaitre X
    J Clin Invest; 2020 Dec; 130(12):6379-6394. PubMed ID: 32790646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
    Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
    Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in Mice.
    Maeoka Y; Ferdaus MZ; Cornelius RJ; Sharma A; Su XT; Miller LN; Robertson JA; Gurley SB; Yang CL; Ellison DH; McCormick JA
    J Am Soc Nephrol; 2022 Mar; 33(3):584-600. PubMed ID: 35064051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and controversies in mutant Cul3-mediated familial hyperkalemic hypertension.
    Ferdaus MZ; McCormick JA
    Am J Physiol Renal Physiol; 2018 May; 314(5):F915-F920. PubMed ID: 29361671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic Hypertension.
    Zhang C; Meermeier NP; Terker AS; Blankenstein KI; Singer JD; Hadchouel J; Ellison DH; Yang CL
    Biochem Biophys Res Commun; 2016 Jan; 469(1):44-48. PubMed ID: 26607111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of KLHL3 and dietary K
    Ostrosky-Frid M; Chávez-Canales M; Zhang J; Andrukhova O; Argaiz ER; Lerdo-de-Tejada F; Murillo-de-Ozores A; Sanchez-Navarro A; Rojas-Vega L; Bobadilla NA; Vazquez N; Castañeda-Bueno M; Alessi DR; Gamba G
    Am J Physiol Renal Physiol; 2021 May; 320(5):F734-F747. PubMed ID: 33682442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension.
    Cornelius RJ; Zhang C; Erspamer KJ; Agbor LN; Sigmund CD; Singer JD; Yang CL; Ellison DH
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1006-F1018. PubMed ID: 29897280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.
    Shibata S; Zhang J; Puthumana J; Stone KL; Lifton RP
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7838-43. PubMed ID: 23576762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
    Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
    Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.
    Cornelius RJ; Si J; Cuevas CA; Nelson JW; Gratreak BDK; Pardi R; Yang CL; Ellison DH
    J Am Soc Nephrol; 2018 Nov; 29(11):2627-2640. PubMed ID: 30301860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased KLHL3 expression is involved in the activation of WNK-OSR1/SPAK-NCC cascade in type 1 diabetic mice.
    Guo Q; Zhang Y; Jiang GR; Zhang C
    Pflugers Arch; 2021 Feb; 473(2):185-196. PubMed ID: 33432425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cullin 3 mutant causing familial hyperkalemic hypertension lacks normal activity in the kidney.
    Maeoka Y; Cornelius RJ; Ferdaus MZ; Sharma A; Nguyen LT; McCormick JA
    Am J Physiol Renal Physiol; 2022 Nov; 323(5):F564-F576. PubMed ID: 36007890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome).
    Glover M; Ware JS; Henry A; Wolley M; Walsh R; Wain LV; Xu S; Van't Hoff WG; Tobin MD; Hall IP; Cook S; Gordon RD; Stowasser M; O'Shaughnessy KM
    Clin Sci (Lond); 2014 May; 126(10):721-6. PubMed ID: 24266877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.
    Ferdaus MZ; Miller LN; Agbor LN; Saritas T; Singer JD; Sigmund CD; McCormick JA
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel
    Chatrathi HE; Collins JC; Wolfe LA; Markello TC; Adams DR; Gahl WA; Werner A; Sharma P
    Hypertension; 2022 Jan; 79(1):60-75. PubMed ID: 34878901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo.
    Yoshida S; Araki Y; Mori T; Sasaki E; Kasagi Y; Isobe K; Susa K; Inoue Y; Bomont P; Okado T; Rai T; Uchida S; Sohara E
    Clin Exp Nephrol; 2018 Dec; 22(6):1251-1257. PubMed ID: 29869755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene.
    Golbang AP; Murthy M; Hamad A; Liu CH; Cope G; Van't Hoff W; Cuthbert A; O'Shaughnessy KM
    Hypertension; 2005 Aug; 46(2):295-300. PubMed ID: 15998707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.